620 related articles for article (PubMed ID: 18217145)
1. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
2. Heparanase coagulation and cancer progression.
Nadir Y; Brenner B
Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
[TBL] [Abstract][Full Text] [Related]
3. Heparanase, tissue factor, and cancer.
Nadir Y; Vlodavsky I; Brenner B
Semin Thromb Hemost; 2008 Mar; 34(2):187-94. PubMed ID: 18645924
[TBL] [Abstract][Full Text] [Related]
4. Heparanase procoagulant effects and inhibition by heparins.
Nadir Y; Brenner B
Thromb Res; 2010 Apr; 125 Suppl 2():S72-6. PubMed ID: 20434010
[TBL] [Abstract][Full Text] [Related]
5. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
6. Heparanase procoagulant activity.
Nadir Y; Brenner B
Thromb Res; 2012 Apr; 129 Suppl 1():S76-9. PubMed ID: 22682139
[TBL] [Abstract][Full Text] [Related]
7. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
[TBL] [Abstract][Full Text] [Related]
8. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
9. Heparanase multiple effects in cancer.
Nadir Y; Brenner B
Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152
[TBL] [Abstract][Full Text] [Related]
10. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
11. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
Brodin E; Iversen N; Hansen JB
J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
[TBL] [Abstract][Full Text] [Related]
12. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
13. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.
Goldshmidt O; Zcharia E; Abramovitch R; Metzger S; Aingorn H; Friedmann Y; Schirrmacher V; Mitrani E; Vlodavsky I
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10031-6. PubMed ID: 12097647
[TBL] [Abstract][Full Text] [Related]
14. Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability.
Skretting G; Lien T; Sandset PM; Iversen N
Thromb Res; 2009 Apr; 123(6):851-5. PubMed ID: 19007969
[TBL] [Abstract][Full Text] [Related]
15. Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI.
Henriquez S; Calderon C; Quezada M; Oliva B; Bravo ML; Aranda E; Kato S; Cuello MA; Gutiérrez J; Quest AF; Owen GI
J Cell Physiol; 2011 Dec; 226(12):3278-85. PubMed ID: 21344386
[TBL] [Abstract][Full Text] [Related]
16. Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium.
Kostovski E; Dahm AE; Iversen N; Hjeltnes N; Østerud B; Sandset PM; Iversen PO
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):254-9. PubMed ID: 21297449
[TBL] [Abstract][Full Text] [Related]
17. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
18. Regulation of heparanase gene expression by estrogen in breast cancer.
Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
[TBL] [Abstract][Full Text] [Related]
19. Relative quantification of glycosaminoglycan-induced upregulation of TFPI-mRNA expression in vitro.
Thyzel E; Kohli S; Siegling S; Prante C; Kleesiek K; Götting C
Thromb Res; 2007; 119(6):785-91. PubMed ID: 16919311
[TBL] [Abstract][Full Text] [Related]
20. Heparanase procoagulant activity in cancer progression.
Nadir Y; Brenner B
Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
